Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2000
11/02/2000DE19919793A1 Neue Sulfonamide New sulfonamides
11/02/2000CA2650236A1 Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142
11/02/2000CA2371662A1 Peptide homodimers and peptide heterodimers, derived from interferon .alpha.2
11/02/2000CA2371241A1 Tgf-.alpha. polypeptides, functional fragments and methods of use therefor
11/02/2000CA2370592A1 Percutaneous absorption preparations containing oxybutynin
11/02/2000CA2370351A1 Inhibition of viral infection using monovalent antigen-binding proteins
11/02/2000CA2370264A1 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof
11/02/2000CA2370195A1 Human membrane-associated proteins
11/02/2000CA2368213A1 Specifically targeted catalytic antagonists and uses thereof
11/01/2000CN1272113A Lyxofuranosyl benzimidazoles as antiviral agents
11/01/2000CN1272105A Compound containing six-membered rings, processes for their preparation, and their use as medicaments
11/01/2000CN1271733A CpG oligonucleotide with specific immunostimulation activity to human immune cell
11/01/2000CN1058010C Novel quinoline carboxylic acid derivatives having 7-(4-aminomethyl-3-oxime) pyrrolidine substituent and process for preparing thereof
11/01/2000CN1058008C Phenyl heterocycles as cyclooxygenase-2 inhibitors
11/01/2000CN1057937C Use of lysozyme dimer and preparations containing same
10/2000
10/31/2000US6140505 Synthesis of benzo fused heterocyclic sulfonyl chlorides
10/31/2000US6140492 Antisense transcript expressed in B lymphocytes and synthetic oligonucleotides useful to inhibit the activity thereof
10/31/2000US6140491 Enzymatic nucleic acid which cleaves ribonucleic acids; has hammerhead motif and has at least one sugar-sugar backbone linkage which is different from a phosphodiester linkage; more stable than ribozymes; antisense agents; viricides
10/31/2000US6140475 Controlled dissolution crosslinked protein crystals
10/31/2000US6140467 Ligand for herpes simplex virus entry mediator and methods of use
10/31/2000US6140363 Administering rosmarinic acid, its derivative or prunella vulgaris extract for suppressing immune response for treatment, prevention, or diagnosis of rejection of transplanted organ or tissue, chronic rejection
10/31/2000US6140361 For inhibiting binding of human immunodeficiency virus rev protein to rev responsive elements (rre)
10/31/2000US6140355 Pharmaceutical compositions containing rifaximin for treatment of vaginal infections
10/31/2000US6140344 For treating pathological conditions such as asthma, rhinitis, eczema and parasitic infections featuring tissue eosinophilia
10/31/2000US6140343 Cholesteryl ester transfer protein inhibitors which are used to elevate highdensity lipoprotein-cholesterol and to lower low density lipoprotein-cholesterol and triglycerides; for treating atherosclerosis, peripheral vascular disease, obesity
10/31/2000US6140340 Derivatives of 2-[3-phenyl-2-propenyl]-1,2,3,4-tetrahydro isoquinoline, their process and their use as fungicides
10/31/2000US6140327 Morpholino-n-ethyl ester derivative of an indole sPLA2 inhibitor
10/31/2000US6140320 For treating hiv(human immunodeficiency virus) infections
10/31/2000US6140318 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
10/31/2000US6140306 Concurrently administering to a patient a (bpi)bactericidal/permeability-increasing protein and a tetracyline antibiotic in the treatment of a patient infected with escherichia gram-negative bacterial species
10/31/2000US6140114 Defective viral vaccine particles obtained in vivo or ex vivo
10/31/2000US6140079 Nucleotide sequence coding staphylococcal protein; for the prevention of bacterial infection and development of bactericides
10/31/2000US6140061 Response regulator
10/31/2000US6140059 Methods for the obtention of human immunodeficiency virsus Type 1 envelope glycoproteins in native and oligomeric form employing recombinant chimeric antigens containing collagenase recognition sites.
10/31/2000US6140043 Pharmaceutical composition comprising a protein, peptide or a functionally equivalent molecule
10/31/2000US6139864 A food or medicine containing a zinc compound and an antimicrobially effective amount of a sugar alcohol mixture without complexing with zinc compound; treatment and prevention of viral cold
10/31/2000US6139856 Composition useful for providing one-step surgical preparation and drape
10/31/2000US6139846 Protein D- an IGD-binding protein of haemophilus influenzae
10/31/2000US6139843 Administering a polypeptide conjugate compositions to enhance immunogenicity, for treatment and prevention of viral infections
10/31/2000US6139841 Activating immune response in an individual for treatment or prevention of cancer
10/31/2000US6139839 Administering to warm-blooded animal an effective amount of an immunotherapy agent that binds to and inhibits the growth-regulating activity of chorionic gonadotropin-like growth-regulating protein of infectious microorganism
10/31/2000US6139836 Lysed and partially lysed red blood cells are concentrated prior to introduction of biologically active agent; resultant carrier red blood cells are stable for extended period of time and can be used for systemic or targeted delivery of drugs
10/31/2000CA2197684C Human-murine chimeric antibodies against respiratory syncytial virus
10/31/2000CA2189658C Controlled-release dosage forms of azithromycin
10/31/2000CA2179305C Novel and improved aminoglycoside formulation for aerosolization
10/31/2000CA2132328C Vaccine containing live virus for therapy of viral diseases and malignancies
10/26/2000WO2000063702A1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes
10/26/2000WO2000063465A1 ACTIVE CARBON ELECTRO-DEPOSITED WITH Ag-I SYSTEM HAVING STERILIZING EFFECT
10/26/2000WO2000063403A2 Recombinant protein production in a human cell using sequences encoding adenovirus e1 protein
10/26/2000WO2000063385A2 Nucleic acid immunization
10/26/2000WO2000063376A1 Adipocyte complement related protein homolog zacrp2
10/26/2000WO2000063374A1 Synthetic transmembrane components
10/26/2000WO2000063372A1 Synthetic signalling molecules
10/26/2000WO2000063364A2 Methods and compositions for inhibiting the function of polynucleotide sequences
10/26/2000WO2000063361A2 A multi-plasmid method for preparing large libraries of polyketides and non-ribosomal peptides
10/26/2000WO2000063348A2 Pharmaceutical composition comprising pim-activated nkt cells, and therapeutic use thereof
10/26/2000WO2000063345A1 PSEUDOMYCIN PRODUCTION BY $i(PSEUDOMONAS SYRINGAE)
10/26/2000WO2000063253A1 Agp-1 fusion protein compositions and methods
10/26/2000WO2000063241A2 Methods and compositions for modulating an immune response
10/26/2000WO2000063240A1 ANTIFUNGAL AGENTS ISOLATED FROM $i(PSEUDOMONAS SYRINGAE)
10/26/2000WO2000063239A1 Novel antifungal compounds
10/26/2000WO2000063237A2 Pseudomycin analogs
10/26/2000WO2000063230A2 49 human secreted proteins
10/26/2000WO2000063225A2 Macrolide antiinfective agents
10/26/2000WO2000063224A2 Macrolide antiinfective agents
10/26/2000WO2000063223A1 Novel 8a- and 9a-15-membered lactams
10/26/2000WO2000063222A2 Novel ribose-substituted aromatic amides, method for the production and use thereof as medicaments
10/26/2000WO2000063213A1 Beta-lactamase inhibiting compounds
10/26/2000WO2000063211A1 Haloalkoxy imidazonaphthyridines
10/26/2000WO2000063204A2 Substituted azoles
10/26/2000WO2000063187A1 Fab i inhibitors
10/26/2000WO2000063178A1 Dibenzoazulene derivatives for treating thrombosis, osteoporosis, arteriosclerosis
10/26/2000WO2000063165A1 Mmp inhibitor
10/26/2000WO2000062835A1 Implant for recreating verterbrae and tubular bones
10/26/2000WO2000062834A1 Endoprosthesis with long-term stability
10/26/2000WO2000062804A2 Identification of sortase gene
10/26/2000WO2000062802A2 Vaccine comprising rsv antigen and cpg oligonucleotide
10/26/2000WO2000062801A2 Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (rsv)
10/26/2000WO2000062800A2 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
10/26/2000WO2000062799A1 Hcv combination therapy, containing ribavirin in association with antioxidants
10/26/2000WO2000062795A2 UTEROGLOBIN IN THE TREATMENT OF IgA MEDIATED AUTOIMMUNE DISORDERS
10/26/2000WO2000062793A2 Pseudomycin antifungal compositions and methods for their use
10/26/2000WO2000062783A2 Ketolide antibacterials
10/26/2000WO2000062776A1 Antifungal compositions
10/26/2000WO2000062767A2 Pharmaceutical compositions containing pyridine or pyrimidine derivates for inhibition of cytokine production and secretion
10/26/2000WO2000062766A2 Uses of ppar-gamma agonists in neutrophil-induced diseases
10/26/2000WO2000062758A1 A method for improving the half-life of soluble viral-specific ligands on mucosal membranes
10/26/2000WO2000062744A2 Skin care compositions containing combination of skin care actives
10/26/2000WO2000062740A2 Skin care compositions containing combination of skin care actives
10/26/2000WO2000062736A2 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion
10/26/2000WO2000062657A2 Improvement of t cell mediated immunity
10/26/2000WO2000038695A3 Aciclovir compositions containing dimethicone
10/26/2000WO2000037646A3 Group b streptococcus proteins, and their use
10/26/2000WO2000035482A3 Novel adjuvant for subunit or component vaccines
10/26/2000WO2000035481A3 Multivalent immunogenic composition containing rsv subunit composition and influenza virus preparation
10/26/2000WO2000035477A3 Multi-component vaccine comprising at least two antigens from haemophilus influenzae
10/26/2000WO2000034444A3 Method and composition for preserving viruses
10/26/2000WO2000034315A8 Purification of echinocandin cyclopeptide compounds
10/26/2000WO2000031120A3 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis
10/26/2000WO2000026385A9 Nucleic acid constructs for genetic immunization
1 ... 1431 1432 1433 1434 1435 1436 1437 1438 1439 1440 1441 1442 1443 1444 1445 1446 1447 1448 1449 1450 1451 ... 1798